ETI41
ETI41 is an orally active selective TLR inhibitor that targets the nucleoside-binding site I of TLR7 (IC50= 0.63 μM) and TLR9 (IC50= 0.16 μM), without affecting surface TLRs (including TLR1/TLR2, TLR2/TLR6, TLR4, and TLR5) . It demonstrates nanomolar activity in cell-based, biophysical, and in vivo studies, effectively inhibiting endosomal TLR-mediated pro-inflammatory signaling. ETI41 suppresses the expression of inflammation-related genes and significantly improves symptoms in mouse models of psoriasis and systemic lupus erythematosus (SLE) . ETI41 is applicable in research related to autoimmune and inflammatory diseases.
Product Specifications
CAS Number
2773474-99-8
Smiles
N=1C2=C (C=C (N2CCCN (C) C) C) C (N) =C3C1CCCCCC3
Molecular Formula
C19H30N4
Molecular Weight
314.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Klebsiella Pneumoniae cyaY Protein (aa 1-106)
NIR1 (Membrane-associated Phosphatidylinositol Transfer Protein 3, Phosphatidylinositol Transfer Protein, Membrane-associated 3, PITPnm 3, Pyk2 N-terminal Domain-interacting Receptor 1, NIR-1, PITPNM3)
CD79b (B-Cell Marker) (rIGB/1842), CF568 conjugate, 0.1mg/mL
TEX9, NT (TEX9, Testis-expressed sequence 9 protein) (MaxLight 550) discontinued